Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 15, 1991 - Issue 4
13
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Hb Isehara (or Hb Redondo) [β92(F8)HIS→SN]: An Unstable Variant with a Proximal Histidine Substitution at the Heme Contact

, , , , &
Pages 279-290 | Received 06 Jan 1991, Accepted 09 May 1991, Published online: 07 Jul 2009
 

Abstract

A 50-year-old Japanese female patient was found to have hemolytic anemia. Isoelectrofocusing of her hemolysate revealed two abnormal hemoglobin bands, one of which was very close to the Hb A2 band, and the other between the Hb A2 and Hb F bands. CM-cellulose column chromatography of the globin prepared from the abnormal hemoglobin showed that the abnormal chain eluted faster than the normal β and δ chains; the βX chain, however, did not separate from the normal β chain in urea cellulose acetate electrophoresis. An instability test of the patient's hemolysate revealed the presence of an unstable component. Structural analysis of the abnormal B chain indicated that the histidine residue at β92(F8) was replaced by an asparagine or aspartic acid residue. DNA amplified by poly-merase chain reaction was sequenced by the dideoxy method. The nucleotide sequence of the β92 codon was AAC instead of CAC, suggesting that the amino acid substitution corresponded to His→tAsn, which is the same as is found in Hb Redondo or ∼92(F8)His→Asn→Asp.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.